Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific

Asia accounted for more than 40% of the world's Non-Hodgkin Lymphoma incidence in 2020, with China contributing the majority.

Other relevant content

Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)

Dyslipidaemia– Global Clinical trial landscape (2023)

Clinical trials in China: unlocking the potential of advanced therapies

Endpoints at BIO 2023: Forging new biotech ties with China

Rapid Subject Enrollment achieved for a Global COVID-19 vaccine phase 3 clinical trial for an…

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Covid-19 Notice important updates

Find content relevant to:

AES 2023 Annual Meeting

OCT East Asia 2023

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Site Management Organization (SMO)

Biometrics and Data Management

Virtual Clinical Trials

Real world data

Laboratory Services

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

Our MISSION is to create career development opportunity for everyone.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Other relevant content

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Gallbladder Cancer: Global Clinical Trial Landscape

Liver Cancer Global Clinical trial landscape- Focus on Asia Pacific

Ovarian Cancer - Global Clinical trial landscape- Focus on Asia Pacific

Rescue study and Oncology CRO services. Local know-how gets pivotal breast cancer trial back on…

Rare Disease – Global Clinical Trial Landscape (2018-2022)

Oncolytic Virus Therapies– Global Clinical Trial Landscape - Focus On Asia Pacific

RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from…

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

ASCO Annual Meeting (In Person)

Oncology CRO services